Sepracor exchanges further $25 million convertibles for stock and cash

New York, Sept. 10 - Sepracor Inc. said it exchanged a further $25 million of its 0% series B convertible senior subordinated notes due 2010 for cash and stock.

The Marlborough, Mass., pharmaceutical company issued 838,000 shares and paid $3.313 million for the notes in a negotiated transaction.

On Sept. 3 Sepracor said it had exchanged $504.18 million principal amount of its 0% series A and series B convertible senior subordinated notes for 16.516 million shares of common stock and $66.457 million in cash in a series of privately negotiated transactions on Aug. 30, Aug. 31 and Sept. 1.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.